← All articles

Dementia, Delirium, or a Medicine? Recognising Cognitive Decline at the Pharmacy Counter

A clinical triage guide for community pharmacists on distinguishing dementia from acute delirium, identifying medicine-induced cognitive impairment, and knowing when to refer urgently.

Why this matters

The pharmacy counter is one of the first places where cognitive decline becomes visible. Collecting prescriptions too early, returning for medicines already dispensed, or struggling to name regular tablets are all signals a pharmacist is well placed to notice before any formal diagnosis has been made. Close to one million people in the UK are living with dementia, yet around four in ten remain undiagnosed.¹

The single most important clinical distinction is between dementia (gradual, progressive cognitive decline) and delirium (acute confusion requiring urgent medical assessment). Delirium signals an acute underlying illness such as infection, dehydration, medicine toxicity, metabolic disturbance, or pain.² In a patient with known dementia, a sudden worsening of confusion is delirium until urgent medical assessment has excluded or treated an acute underlying cause. The decision about whether delirium can be managed without hospital assessment belongs to the assessing clinician, not the community pharmacist.

Medicines are a major and reversible cause of cognitive impairment. NICE NG97 specifically recommends considering minimising medicines with increased anticholinergic burden when assessing suspected dementia referral and during medication reviews.³ Anticholinergic medicines, benzodiazepines, Z-drugs, opioids, gabapentinoids, and sedating antihistamines can all produce confusion that resolves once the cause is removed. Check the dispensing record, recent medicine changes, and any medicines brought into the pharmacy before assuming dementia progression.

NICE CG103 is written for hospital and long-term care settings, but its core recognition points are useful for pharmacy triage: acute onset, fluctuation, inattention, altered alertness, and new hallucinations should be treated as urgent until a clinician has assessed the patient.²

Features suggesting gradual cognitive decline vs urgent red flags

FeatureGradual cognitive decline (non-urgent)Red flag ⚠
Onset of confusionGradual over months or years, function slowly decliningSudden onset over hours or days, often with agitation or drowsiness.²
Level of consciousnessAlert, orientated, able to follow a simple conversationReduced consciousness, severely drowsy, or difficult to rouse: treat as urgent.²
FluctuationConsistent cognitive baseline with slow gradual progressionMental state varies noticeably hour to hour or day to day.²
Physical symptomsNo accompanying fever, pain, or new physical complaintsFever, dysuria, cough, recent fall or possible head injury, vomiting, or refusing food and fluids
BehaviourRepetitive questions, word-finding difficulty, memory lapsesVisual hallucinations, paranoia, restlessness, or uncharacteristic aggression.²
Prescription historyEstablished, stable collection pattern over monthsSudden change in timing, dose confusion, or repeat requests for already-dispensed medicines
Recent medicinesNo new medicines added in the last four weeksRecent addition of anticholinergic, benzodiazepine, opioid, Z-drug, gabapentinoid, or antihistamine
Blood glucoseNo diabetes medicines, or diabetes well-managed and stableDiabetes on insulin or sulfonylurea: confusion, sweating, tremor, or pallor may indicate hypoglycaemia.⁷

Think Delirium or Dementia if Your Patient Says...

When a carer or patient uses any of these phrases, pause the consultation and use TRACE to assess urgency.

  • "She keeps asking me the same question over and over again, even minutes after I have answered."
  • "He forgot he had already collected his tablets and came back for them again."
  • "She was fine yesterday but this morning I could not get any sense out of her."
  • "He does not recognise people he has known for years."
  • "She has been taking her blood pressure tablets twice because she forgets she has already had them."
  • "He has been getting really muddled about his medicines, and he has never had trouble before."
  • "She is a diabetic and she looks really pale and shaky and is not making any sense."

The third phrase is the most urgent: sudden confusion in a person with known cognitive decline requires same-day medical assessment, not reassurance that the condition has progressed.

🛑 TRACE: Triaging Cognitive Change at the Counter

Use TRACE when a patient or carer raises concerns about memory, confusion, or a change in behaviour. NICE CG103 supports treating acute onset, fluctuation, and altered alertness as urgent until a clinician has assessed the patient.²

T
Timeframe

Ask: when did this start? Hours or days points to delirium. Months or years points to dementia. The timeframe determines the urgency of the referral.

R
Recent changes

Has anything changed in the past four weeks? New medicines, a suspected infection, a fall, dehydration, or a change of environment can all trigger acute confusion. Check the dispensing record for recent additions.

A
Alertness

Can the patient hold a simple conversation without losing track? Reduced consciousness, drowsiness, agitation, or fluctuating mental state points to delirium, not dementia.²

C
Counter patterns

Prescription timing tells a story. Collecting too early, requesting medicines already dispensed, or confusing a dose regimen the patient has managed for years are all clinical signals worth acting on.

E
Escalate or refer

Call 999 if the patient is acutely unwell, has reduced consciousness, or cannot be kept safe. Arrange same-day hospital assessment for suspected delirium. Non-urgent GP for gradual cognitive decline with no acute features.

Do not reassure carers that a sudden change is normal disease progression without same-day medical assessment.

Reversible Causes and High-Risk Presentations Not to Miss

Several presentations mimic dementia but have treatable causes, or change the urgency of the referral.

  • Hypoglycaemia: In a person with diabetes taking insulin or a sulfonylurea, acute confusion with sweating, tremor, pallor, or drowsiness may be hypoglycaemia.⁷ If the patient is fully conscious, cooperative, and able to swallow safely, give fast-acting carbohydrate. If the patient is unconscious, fitting, very drowsy, unable to swallow safely, or not improving: call 999.
  • Medicine-induced cognitive impairment: NICE NG97 specifically recommends considering minimising medicines with increased anticholinergic burden when assessing for suspected dementia referral and during medication reviews.³ Review the full medicine list for: anticholinergics (tricyclic antidepressants, bladder antimuscarinics, first-generation antihistamines, older antipsychotics), benzodiazepines, Z-drugs, opioids, gabapentinoids, corticosteroids, recent dose increases, duplicate medicines, adherence errors, renal impairment risk, and any medicines added since a recent hospital discharge.
  • Depression presenting with apparent cognitive impairment: Older adults with depression can present with apparent memory loss, slowed thinking, and withdrawal. If low mood, loss of interest, or social withdrawal accompanies cognitive symptoms, include this in the GP referral.
  • Younger-onset dementia (under 65): Around 15,000 people in the UK carry a dementia diagnosis before the age of 65.¹ Cognitive symptoms in a working-age patient still warrant GP referral: do not dismiss them as stress or burnout.
  • Dementia with Lewy bodies and Parkinson's disease dementia: Antipsychotics can worsen motor symptoms and may cause severe sensitivity reactions. Seek urgent same-day medical advice if deterioration follows antipsychotic use. Call 999 if there is reduced consciousness, severe rigidity, high temperature, collapse, breathing or swallowing difficulty, or immediate risk to self or others.
  • Acute confusion after a fall or possible head injury: Arrange urgent medical assessment. Call 999 if there is loss of consciousness, worsening drowsiness, vomiting, anticoagulant use, severe headache, seizure, new neurological signs, or the patient cannot be kept safe.
  • Safeguarding: A patient who appears confused and fearful, or who discloses that medicines are being managed or withheld by another person, may be at risk. Follow your pharmacy safeguarding policy. If there is immediate danger, suspected abuse, coercion, or the patient cannot safely leave, contact emergency services, police, or social care as locally required. Certainty is not required before raising a concern.

A patient whose prescription is routinely collected by a third party, and who now presents confused, should prompt a safeguarding consideration.

What to do in pharmacy

Call 999 immediately if: the patient has collapsed or is unresponsive; the patient has reduced consciousness or is severely drowsy and difficult to rouse; there are signs of stroke (facial weakness, arm weakness, speech difficulty); there are signs of sepsis (fever with rapid deterioration or mottled skin with new acute confusion); the patient is suspected of overdose or poisoning; there is acute confusion after a fall with possible head injury in a patient who is deteriorating, vomiting, on anticoagulants, or cannot be kept safe; hypoglycaemia is suspected and the patient is unconscious, fitting, very drowsy, unable to swallow safely, or not responding to fast-acting carbohydrate; or the patient is in immediate danger of harming themselves or others. Do not leave the patient alone. Do not allow an acutely confused patient to drive or travel home unaccompanied. Do not give food, drink, or oral medicines to a patient with reduced consciousness or who cannot swallow safely.
Most suspected delirium needs same-day hospital assessment for investigation and treatment of the precipitating cause.⁵ Urgent GP or NHS 111 may be appropriate only where the patient is stable, not acutely unsafe, and a clinician can assess the same day. Refer urgently if: confusion has started suddenly within hours or days; a patient with known dementia has changed sharply from their usual baseline; confusion is accompanied by fever, pain, urinary symptoms, cough, vomiting, a recent fall, reduced fluid intake, or a recent new medicine; or there is a safeguarding concern. A community pharmacist cannot diagnose or exclude delirium, and cannot decide whether delirium is safe for non-hospital management. Do not attempt to manage acute confusion in the pharmacy.
A non-urgent GP referral is appropriate when a carer or patient describes gradually worsening memory or word-finding difficulty over months, with no acute features, no safety concerns at home, and no recent medicine changes that could account for the symptoms. Share relevant observations from the dispensing record with the referral. Do not supply OTC sedating antihistamines, including promethazine, diphenhydramine, or chlorphenamine, where confusion, delirium risk, falls risk, or cognitive decline is suspected, without GP guidance.

Key takeaways

  • A sudden change in a patient known to have dementia is delirium until urgent medical assessment has excluded an acute underlying cause: refer for same-day hospital assessment rather than assuming disease progression.
  • Check the dispensing record, recent medicine changes, and any medicines brought into the pharmacy before assuming dementia: anticholinergic medicines, benzodiazepines, Z-drugs, opioids, and gabapentinoids are all reversible causes of cognitive impairment.
  • Prescription patterns are a clinical window: patients collecting too early, confusing doses, or returning for medicines already dispensed may be showing the first signs of cognitive decline before any formal diagnosis has been made.

📚 References

  1. Alzheimer's Research UK. Dementia Statistics Hub: prevalence and incidence. 2024. https://dementiastatistics.org/about-dementia/prevalence-and-incidence/
  2. National Institute for Health and Care Excellence. Delirium: prevention, diagnosis and management in hospital and long-term care. Clinical guideline CG103. London: NICE; 2010 (updated 2023). https://www.nice.org.uk/guidance/cg103
  3. National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. NICE guideline NG97. London: NICE; 2018. https://www.nice.org.uk/guidance/ng97
  4. National Institute for Health and Care Excellence. Clinical Knowledge Summary: Dementia. London: NICE; 2024. https://cks.nice.org.uk/topics/dementia/
  5. National Institute for Health and Care Excellence. Clinical Knowledge Summary: Delirium. London: NICE; 2024. https://cks.nice.org.uk/topics/delirium/
  6. NHS England. Dementia. Available from: NHS England. https://www.england.nhs.uk/mental-health/dementia/
  7. National Institute for Health and Care Excellence. Clinical Knowledge Summary: Hypoglycaemia. London: NICE; 2024. https://cks.nice.org.uk/topics/hypoglycaemia/

Download the checklist

Download the one-page dementia and delirium checklist

Continuing professional development

Test your knowledge

Answer 10 questions on this article. Score 70% or more and you will receive a dated, verifiable certificate for 1 hours of CPD, ready for your portfolio.

Disclaimer: For educational use by healthcare professionals only. Does not replace clinical judgement, local pathways, or NICE guidance. Not for public self-diagnosis.